Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedAug 2, 2017fentaNYL 2 mcg/mL + BUPIvacaine 0.1% PF in 0.9% NS 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1014-2017Class IITerminatedAug 2, 2017fentaNYL 10 mcg/mL PF in Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1013-2017Class IITerminatedAug 2, 2017fentaNYL 10 mcg/mL PF in NS 1 mL Fill in 3 mL syringeLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1012-2017Class IITerminatedAug 2, 2017fentaNYL 2 mcg/mL+Bupivacaine 0.0625% PF in 0.9% Sodium Chloride 250 mLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1011-2017Class IITerminatedAug 2, 2017fentaNYL as citrate 5 mcg/mL in 0.9% Sodium Chloride 1 mL in Single Dose syringeLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1010-2017Class IITerminatedAug 2, 2017fentaNYLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1009-2017Class IITerminatedAug 2, 2017fentaNYLLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1008-2017Class IITerminatedAug 2, 2017BUPIVacaine HCl 0.2% IN 0.9% Sodium Chloride 250 mL Bag Preservative FreeLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1007-2017Class IITerminatedAug 2, 2017BUPIVacaine HCl 0.125% In 250 mL 0.9% Sodium Chloride BagLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1006-2017Class IITerminatedAug 2, 2017BUPIVacaine HCl 0.1% PFLack of Assurance of Sterility; product has the potential to leak.SCA Pharmaceuticals · D-1005-2017Class IITerminatedAug 2, 2017PHENYLephrine HCl 10 mg in 0.9% Sodium ChlorideLack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.SCA Pharmaceuticals · D-1004-2017Class IITerminatedAug 2, 2017MAGNESIUM Sulfate 4 g added to 100 mL 0.9% Sodium ChlorideLack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.SCA Pharmaceuticals · D-1003-2017Class IITerminatedAug 2, 2017Diltiazem 125 mg in 0.9% Sodium ChlorideLack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.SCA Pharmaceuticals · D-1002-2017Class IITerminatedAug 2, 2017ceFAZolin 3 g added to 100 mL 0.9% Sodium ChlorideLack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.SCA Pharmaceuticals · D-1001-2017Class IITerminatedAug 2, 2017fentaNYLLack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.SCA Pharmaceuticals · D-1000-2017Class IITerminatedAug 2, 2017morphine sulfate 1 mg per mL in 0.9% Sodium ChlorideLack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.SCA Pharmaceuticals · D-0999-2017Class IIITerminatedJul 26, 2017Obagi-C Rx System C-Therapy Night CreamLabeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the...Valeant Pharmaceuticals North America LLC · D-0998-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 5% Dextrose InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0997-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0996-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 5% Dextrose InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0995-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0994-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 5% Dextrose InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0993-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0992-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0991-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0990-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 5% Dextrose InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0989-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride Injection 20 mMol in 100 mL in 150 mL Intravia BagLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0988-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride Injection 15 mMol in a) 100 mL in 150 mL Intravia Bag Service...Lack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0987-2017Class IITerminatedJul 26, 2017Potassium PHOSphate in 0.9% Sodium Chloride InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0986-2017Class IITerminatedJul 26, 2017Succinylcholine Chloride InjectionLack of Assurance of Sterility; media fill failure at manufacturerPharMedium Services, Llc · D-0985-2017Class IIITerminatedJul 26, 2017Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg 30 tablets per BottleFailed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.Teva Pharmaceuticals USA · D-0984-2017Class IIITerminatedJul 26, 2017Buprenorphine and Naloxone Sublingual TabletsFailed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.Teva Pharmaceuticals USA · D-0983-2017Class IIITerminatedJul 26, 2017PONSTELFailed Dissolution Specifications: Low dissolution results were obtained during stability testingShionogi Inc. · D-0982-2017Class IIITerminatedJul 26, 2017Mefenamic AcidFailed Dissolution Specifications: Low dissolution results were obtained during stability testingShionogi Inc. · D-0981-2017Class IIITerminatedJul 26, 2017Argatroban InjectionFailed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time pointHospira Inc., A Pfizer Company · D-0980-2017Class IITerminatedJul 19, 2017Potassium PHOSphate added to 0.9% Sodium Chloride 250 mL Bag 30 mMolLack of sterility assuranceSCA Pharmaceuticals · D-0979-2017Class IITerminatedJul 19, 2017Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMolLack of sterility assuranceSCA Pharmaceuticals · D-0978-2017Class IITerminatedJul 19, 2017Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMolLack of sterility assuranceSCA Pharmaceuticals · D-0977-2017Class IITerminatedJul 19, 2017Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 10 mMolLack of sterility assuranceSCA Pharmaceuticals · D-0976-2017Class IITerminatedJul 19, 2017CVS Health Baby Eczema Moisturizing CreamMicrobial Contamination of Non Sterile Products; out of specification Total Plate CountSigan Industries Inc. · D-0975-2017